Company Overview of Molecular Biosystems, Inc.
Molecular Biosystems, Inc., a biomedical company, develops medical products that diagnose human disease. The company develops and supplies direct, non-radioactively labeled nucleic acid probe products; and imaging products, including Aibunex, an injectable contrast agent for use in ultrasound imaging. The company was incorporated in 1980 and is based in San Diego, California. As of January 3, 2001, Molecular Biosystems, Inc. operates as a subsidiary of Alliance Pharmaceutical Corp.
10030 Barnes Canyon Road
San Diego, CA 92121
Founded in 1980
Key Executives for Molecular Biosystems, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Molecular Biosystems, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.